1,3-Propanediamine, N3-[3-(1,3-benzodioxol-5-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-N1,N1-dimethyl-

1,3-Propanediamine, N3-[3-(1,3-benzodioxol-5-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-N1,N1-dimethyl- Suppliers list
Company Name: Shanghai Beckham Medical Technology Co., Ltd  
Tel: 13816613772
Email: huahero21@sina.com
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: Shanghai Chaolan Chemical Technology Center  
Tel: QQ:65489617 13301690235
Email: Sales@ATKchemical.com
Company Name: Zhejiang Huida Biotech Co., LTD  
Tel: 0571-89903022 18679456698
Email: zilong@hizyme.com
Company Name: Bide Pharmatech Ltd.  
Tel: 400-1647117 13681763483
Email: product02@bidepharm.com
1,3-Propanediamine, N3-[3-(1,3-benzodioxol-5-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-N1,N1-dimethyl- Basic information
Product Name:1,3-Propanediamine, N3-[3-(1,3-benzodioxol-5-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-N1,N1-dimethyl-
Synonyms:1,3-Propanediamine, N3-[3-(1,3-benzodioxol-5-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-N1,N1-dimethyl-;RET-IN-3;N1-(3-(Benzo[d][1,3]dioxol-5-yl)pyrazolo[1,5-a]pyrimidin-5-yl)-N3,N3-dimethylpropane-1,3-diamine;RET-IN-3, 10 mM in DMSO
CAS:2414374-53-9
MF:C18H21N5O2
MW:339.39
EINECS:
Product Categories:
Mol File:2414374-53-9.mol
1,3-Propanediamine, N3-[3-(1,3-benzodioxol-5-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-N1,N1-dimethyl- Structure
1,3-Propanediamine, N3-[3-(1,3-benzodioxol-5-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-N1,N1-dimethyl- Chemical Properties
solubility DMSO: Sparingly soluble: 1-10 mg/mL
Ethanol: Sparingly soluble: 1-10 mg/mL
form Solid
color Off-white to light yellow
Safety Information
MSDS Information
1,3-Propanediamine, N3-[3-(1,3-benzodioxol-5-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-N1,N1-dimethyl- Usage And Synthesis
DescriptionRET-IN-3 is a is a selective RETV804M kinase inhibitor.
UsesRET-IN-3 (compound 34) is a selective RETV804M kinase inhibitor, with an IC50 of 19 nM[1].
References[1] Rebecca Newton, et al. Discovery and Optimization of wt-RET/KDR-Selective Inhibitors of RET V804M Kinase. ACS Med Chem Lett. 2020 Feb 28;11(4):497-505. DOI:10.1021/acsmedchemlett.9b00615
1,3-Propanediamine, N3-[3-(1,3-benzodioxol-5-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-N1,N1-dimethyl- Preparation Products And Raw materials
Tag:1,3-Propanediamine, N3-[3-(1,3-benzodioxol-5-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-N1,N1-dimethyl-(2414374-53-9) Related Product Information
Pyrazolo[1,5-a]pyrimidine-5,7-diamine, 3-(3,4-dimethoxyphenyl)-N5-(1,2,2,6,6-pentamethyl-4-piperidinyl)-6-phenyl- 1,3-Propanediamine, N3-[3-(1,3-benzodioxol-5-yl)pyrazolo[1,5-a]pyrimidin-5-yl]-N1,N1-dimethyl- 4-(3'-Hydroxyphenyl)amino-6,7-dimethoxyquinazoline, HCl 17,19-Metheno-1H,5H-cyclopent[5,6][1,4]oxazino[3,4-i]pyrazolo[4,3-f]pyrido[3,2-l][1,4,8,10]oxatriazacyclotridecin-14(11H)-one, 7-fluoro-2,3,3a,12,13,20a-hexahydro-11-methyl-, (3aS,11R,20aR)- 2-Pyridinecarboxamide, 4-[4-[[[[2-fluoro-5-[1,2,2,2-tetrafluoro-1-(trifluoromethyl)ethyl]phenyl]amino]carbonyl]amino]phenoxy]-N-methyl- RET Extracellular Domain (human, recombinant)